Variables | n | % | |
---|---|---|---|
All | Â | 59 | 100.0 |
Age | ≤50 | 13 | 22.0 |
 | > 50 | 46 | 78.0 |
Histology | DIC | 49 | 83.1 |
 | Others | 10 | 16.9 |
Tumour size (mm) | ≤20 | 34 | 57.6 |
 | > 20 | 25 | 42.4 |
LNM statusa | 0 | 17 | 28.8 |
 | ≥1 | 42 | 71.2 |
TNM classification | I | 14 | 23.7 |
 | II | 22 | 37.3 |
 | III | 23 | 39.0 |
Grade | 1 and 2 | 36 | 63.2 |
 | 3 | 21 | 36.8 |
Hormone receptor statusb | Negative | 8 | 13.6 |
 | Positive | 51 | 86.4 |
HER2 statusc | Normal | 16 | 27.1 |
 | Amplified | 43 | 72.9 |
Ki-67 proliferative indexd | Low | 35 | 59.3 |
 | High | 24 | 40.7 |
Tumour multifocality | Negative | 51 | 87.9 |
 | Positive | 7 | 12.1 |
CTC anye | Negative | 30 | 50.8 |
 | Positive | 29 | 49.2 |
CTC epithelial | Negative | 45 | 76.3 |
 | Positivef | 14 | 23.7 |
CTC mesenchymal | Negative | 40 | 67.8 |
 | Positiveg | 19 | 32.2 |
CTCe and LNM status | Negat. / Posit. | 29 | 50.0 |
 | Posit. / Negat. | 16 | 27.6 |
 | Posit. / Posit. | 13 | 22.4 |